We are live on ! Find out more
CH

CVS Health Portfolio holdings

AUM $225M
1-Year Est. Return 8.77%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+8.77%
3 Year Est. Return
+48.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$212M
AUM Growth
+$18M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
8 quarters
Top 10 Avg Time Held
8 quarters
Top 20 Avg Time Held
8 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.74%
2 Financials 0.15%
3 Healthcare 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$829B
$151M 71.11%
287,891
– –
2023 Q1
4 quarters
VYM icon
2
Vanguard High Dividend Yield ETF
VYM
$79.7B
$30.5M 14.4%
252,032
– –
2022 Q1
8 quarters
HDV
3
iShares Core High Dividend ETF
HDV
$14.8B
$30.1M 14.21%
1,365,550
– –
2021 Q4
9 quarters
PRU icon
4
Prudential Financial
PRU
$38.6B
$315K 0.15%
2,683
– –
2021 Q4
9 quarters
HCAT icon
5
Health Catalyst
HCAT
$130M
$243K 0.11%
32,273
– –
2021 Q4
9 quarters
LMDXW
6
DELISTED
LumiraDx Limited Warrant
LMDXW
$40.7K 0.02%
5,352,106
– –
2021 Q4
9 quarters

Similar funds

CVS Health's Q1 2024 Portfolio in Review

As of Q1 2024, CVS Health held 6 positions worth $212M, up 9.3% from $194M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. CVS Health opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, up from 100% a quarter earlier, followed by Financials and Healthcare.

  • CVS Health's ten largest holdings make up 100% of its $212M portfolio in Q1 2024.
  • CVS Health opened 0 new positions and closed 0 in Q1 2024.
  • CVS Health's portfolio value rose 9.3% quarter-over-quarter to $212M.

Based on CVS Health's 13F filing for Q1 2024, filed 3 May 2024.